Holen Sie sich die Stockscreener-App
3.027
0.43%
-0.013
Schlusskurs vom Vortag:
$3.04
Offen:
$3.05
24-Stunden-Volumen:
6,335
Relative Volume:
0.13
Marktkapitalisierung:
$16.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.35M
KGV:
-0.9925
EPS:
-3.05
Netto-Cashflow:
$-11.88M
1W Leistung:
+3.31%
1M Leistung:
+0.90%
6M Leistung:
-16.61%
1J Leistung:
-17.30%
1-Tages-Spanne:
$3.01
$3.0501
1-Wochen-Bereich:
$2.86
$3.10
52-Wochen-Spanne:
$2.6838
$6.1683
Lipocine Inc Stock (LPCN) Company Profile
Firmenname
Lipocine Inc
Sektor
Branche
Telefon
801 994 7383
Adresse
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Vergleichen Sie LPCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LPCN
Lipocine Inc
|
3.027 | 16.47M | 0 | -16.35M | -11.88M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-06-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2018-01-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-01-11 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2017-12-08 | Fortgesetzt | H.C. Wainwright | Buy |
| 2016-10-07 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-07-22 | Eingeleitet | ROTH Capital | Buy |
| 2015-06-23 | Eingeleitet | Canaccord Genuity | Buy |
Alle ansehen
Lipocine Inc Aktie (LPCN) Neueste Nachrichten
Can technical indicators confirm Lipocine Inc.’s reversal2025 Earnings Impact & Reliable Trade Execution Plans - Newser
What machine learning models say about Lipocine Inc.July 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
What the charts say about Lipocine Inc. today2025 Breakouts & Breakdowns & Fast Gain Swing Trade Alerts - Newser
What makes Lipocine Inc. stock price move sharplyInsider Buying & Expert Verified Stock Movement Alerts - Newser
Multi factor analysis applied to Lipocine Inc.Portfolio Risk Report & Growth Focused Stock Pick Reports - Newser
Pattern recognition hints at Lipocine Inc. upsideChart Signals & Safe Entry Momentum Tips - Newser
Real time alert setup for Lipocine Inc. performanceJuly 2025 Trends & Free Real-Time Market Sentiment Alerts - Newser
Advanced analytics toolkit walkthrough for Lipocine Inc.Quarterly Trade Review & Community Consensus Trade Alerts - Newser
Visualizing Lipocine Inc. stock with heatmapsEarnings Risk Report & Verified Swing Trading Watchlists - Newser
Combining price and volume data for Lipocine Inc.Trade Analysis Summary & Weekly Top Performers Watchlists - Newser
Is Lipocine Inc. vulnerable to short sellersJuly 2025 Sector Moves & Risk Controlled Daily Trade Plans - thegnnews.com
When is the best time to exit Lipocine Inc.2025 Bull vs Bear & AI Forecasted Stock Moves - Newser
Visual analytics tools that track Lipocine Inc. performanceIndex Update & Low Drawdown Trading Techniques - Newser
Moving Average Trends for Lipocine Inc. Stock: What They IndicateDollar Strength & Fast Gain Stock Trading Tips - Newser
Lipocine (NASDAQ:LPCN) Upgraded at Alliance Global Partners - Defense World
Lipocine Inc. stock trend outlook and recovery pathJuly 2025 Pullbacks & Verified Chart Pattern Signals - Newser
Is Lipocine Inc. reversing from oversold territoryChart Signals & Reliable Price Action Trade Plans - Newser
Tools to assess Lipocine Inc.’s risk profileCommunity Picked Stocks with Trade Insights - Newser
Lipocine to Host Virtual R&D Investor Event to Discuss LPCN 1154 (BRLIZIO) as a Treatment for Postpartum Depression on July 9, 2025 - 富途牛牛
Postpartum Depression Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | GH Research, Reunion Neuroscience, Lipocine, Brii Biosciences Limited - Barchart.com
What earnings revisions data tells us about Lipocine Inc.AI Trend Detection for Entry Timing - Newser
Detecting support and resistance levels for Lipocine Inc.Daily Market Entry Strategy with Tools - Newser
Lipocine Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingBull Market Summary and Recovery Outlook - Newser
Lipocine (LPCN) Projected to Post Earnings on Thursday - Defense World
Lipocine: Q2 Earnings Snapshot - New Haven Register
Lipocine Inc. Reports Q2 2025 Financial Results - TipRanks
Lipocine Inc.’s volatility index tracking explainedWeekly Price Target Forecast and Alerts - Newser
Finanzdaten der Lipocine Inc-Aktie (LPCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.41%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):